Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study

Fig. 3

Kaplan-Meier survival analysis of 28-day survival according to statin therapy for the three acute respiratory distress syndrome (ARDS) groups. The Kaplan-Meier survival curves censored at day 28 for each ARDS group (mild, moderate, and severe) according to the presence of statin therapy. Treatment with statins only significantly impacted 28-day survival among the patients with severe sepsis-associated ARDS (P = 0.0193, log-rank test)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us